Reliable, non-invasive biological markers of the severity of radiotherapy-induced damage to the gastrointestinal tract are not available. Clinicians continue to use symptom scores as surrogate indicators of toxicity.AIM: To determine whether levels of potential biochemical markers of mucosal toxicity change during pelvic radiotherapy.